H.U. Group Holdings, Inc. (4544.T)

JPY 2714.0

(2.16%)

EBITDA Summary of H.U. Group Holdings, Inc.

  • H.U. Group Holdings, Inc.'s latest annual EBITDA in 2023 was 13.64 Billion JPY , down -59.75% from previous year.
  • H.U. Group Holdings, Inc.'s latest quarterly EBITDA in 2024 Q1 was 5.68 Billion JPY , up 376.19% from previous quarter.
  • H.U. Group Holdings, Inc. reported an annual EBITDA of 43.07 Billion JPY in 2022, down -31.95% from previous year.
  • H.U. Group Holdings, Inc. reported an annual EBITDA of 65.11 Billion JPY in 2021, up 66.21% from previous year.
  • H.U. Group Holdings, Inc. reported a quarterly EBITDA of 2.57 Billion JPY for 2023 Q4, down -27.34% from previous quarter.
  • H.U. Group Holdings, Inc. reported a quarterly EBITDA of N/A for 2023 FY, down -59.75% from previous quarter.

Annual EBITDA Chart of H.U. Group Holdings, Inc. (2023 - 2005)

Historical Annual EBITDA of H.U. Group Holdings, Inc. (2023 - 2005)

Year EBITDA EBITDA Growth
2023 13.64 Billion JPY -59.75%
2022 43.07 Billion JPY -31.95%
2021 65.11 Billion JPY 66.21%
2020 37.88 Billion JPY 105.04%
2019 21.27 Billion JPY -14.36%
2018 24.35 Billion JPY -61.03%
2017 2.88 Billion JPY 35.04%
2016 41.18 Billion JPY 1.55%
2015 41.04 Billion JPY -7.11%
2014 40.29 Billion JPY 0.42%
2013 41.31 Billion JPY 4.37%
2012 39.47 Billion JPY 11.98%
2011 34.82 Billion JPY 10.66%
2010 30.28 Billion JPY 9.42%
2009 28.96 Billion JPY 11.57%
2008 25.79 Billion JPY 6.2%
2007 23.9 Billion JPY 4.03%
2006 23.53 Billion JPY -61.53%
2005 22 Billion JPY 0.0%

Peer EBITDA Comparison of H.U. Group Holdings, Inc.

Name EBITDA EBITDA Difference
Shin Nippon Biomedical Laboratories, Ltd. 8.98 Billion JPY -51.951%
DNA Chip Research Inc. -217 Million JPY 6388.94%
Cosmo Bio Company,Limited 669 Million JPY -1939.91%
FALCO HOLDINGS Co., Ltd. 3.13 Billion JPY -335.728%
BML, Inc. 16.41 Billion JPY 16.883%
Human Metabolome Technologies, Inc. 306.48 Million JPY -4352.761%
Precision System Science Co., Ltd. -661.75 Million JPY 2162.259%